Table 3.
T cell subset |
Non-diabetic n = 9 |
Pre-diabetic n = 8 |
Diabetic n = 9 |
p-Value* |
---|---|---|---|---|
Total CD4+ T cells | 7.5% | 10.9% | 17.2% | 0.004 |
CD4 TNAIVE | 0.6% | 1.1% | 2.0% | 0.03 |
CD4 TCENTRAL MEMORY | 5.9% | 7.8% | 11.9% | 0.02 |
CD4 TEFFECTOR MEMORY | 14.7% | 18.2% | 22.3% | 0.04 |
CD4 | 4.9% | 8.9% | 7.3% | 0.04 |
Total CD8+ T cells | 5.4% | 6.2% | 10.0% | 0.09 |
TNAIVE | 1.5% | 0.6% | 4.2% | 0.28 |
TCENTRAL MEMORY | 6.9% | 5.5% | 12.8% | 0.45 |
TEFFECTOR MEMORY | 11.9% | 9.3% | 17.0% | 0.19 |
5.0% | 5.7% | 9.0% | 0.12 |
Univariable linear regression. The association of total CD4+ T cell CD69 expression with progressive glucose intolerance was robust to adjustment for BMI (p = 0.03) and to age (p = 0.01) in separate models.
The bolded values are p-values <0.05, indicating statistical significance.